Urgent.News

600+ sources. One page. See who else covered it.

Editions

Business

Goldman in talks with investors on Nvidia financing deal after landing prized role, sources say

Goldman in talks with investors on Nvidia financing deal after landing prized role, sources say

Goldman Sachs is engaged in discussions with potential investors regarding participation in Nvidia's $500 billion AI financing initiative, as revealed by sources familiar with the matter. The deal, which involves major financial institutions, is a result of Goldman's strong relationship with the chipmaker. The financing aims to raise capital for AI infrastructure, with asset managers planning to take a significant share.

Goldman Sachs is expected to provide junior capital and private credit financing through its asset management arm, while its investment bank will assist in placing the debt in private credit funds and public debt markets. This role marks a culmination of years-long ties between Goldman Sachs and Nvidia, with the bank offering advice on various transactions and technology financing deals involving Nvidia.

The financing structure differs from previous AI infrastructure deals, which relied heavily on vendor guarantees. Nvidia has the option to backstop up to $125 billion in the deal, aiming to create an asset-backed market for AI compute. The move highlights the growing demand for AI computing capacity, as governments, companies, and startups seek to build data centers to support AI workloads.

Written by urgent.news from CNA - Business's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at channelnewsasia.com →

More in Business

Celltrion Vegzelma Matches Original Drug in Study

The anticancer drug ‘Vegzelma (ingredient name bevacizumab)’ developed by Celltrion objectively proved its pharmacokinetic equivalence to the original drug through research results analyzing…

  • Vegzelma matches original drug in pharmacokinetic study.
  • Research integrates data from 834 subjects across trials.
  • Celltrion plans to use findings for clinical competitiveness.

Korea Seeks to Become Next-Gen. Nuclear Hub in SMR Talks With Bill Gates

Bill Gates, the Microsoft co-founder and chair of the Gates Foundation who also leads next-generation nuclear power company TerraPower, arrived in South Korea via Gimpo Airport on a private jet at…

  • Bill Gates visits South Korea on August 13 to discuss SMRs.
  • Gates plans closed-door meeting with National Assembly Speaker Cho Jung-sik.
  • SMRs seen as solution to power shortages in AI era data centers.